Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
Saved in:
| Title: | Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. |
|---|---|
| Authors: | Shen M; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Smith HA; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Wei Y; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Jiang YZ; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China., Zhao S; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China., Wang N; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Rowicki M; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Tang Y; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Hang X; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Wu S; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China., Wan L; Department of Molecular Biology, Princeton University, Princeton, NJ, USA., Shao ZM; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China., Kang Y; Department of Molecular Biology, Princeton University, Princeton, NJ, USA. ykang@princeton.edu.; Cancer Metabolism and Growth Program, The Cancer Institute of New Jersey, New Brunswick, NJ, USA. ykang@princeton.edu.; Ludwig Institute for Cancer Research Princeton Branch, Princeton, NJ, USA. ykang@princeton.edu. |
| Source: | Nature cancer [Nat Cancer] 2022 Jan; Vol. 3 (1), pp. 60-74. Date of Electronic Publication: 2021 Nov 29. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35121988 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shen+M%22">Shen M</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Smith+HA%22">Smith HA</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Wei+Y%22">Wei Y</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+YZ%22">Jiang YZ</searchLink>; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Zhao+S%22">Zhao S</searchLink>; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Wang+N%22">Wang N</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Rowicki+M%22">Rowicki M</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Hang+X%22">Hang X</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Wu+S%22">Wu S</searchLink>; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Wan+L%22">Wan L</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Shao+ZM%22">Shao ZM</searchLink>; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Kang+Y%22">Kang Y</searchLink>; Department of Molecular Biology, Princeton University, Princeton, NJ, USA. ykang@princeton.edu.; Cancer Metabolism and Growth Program, The Cancer Institute of New Jersey, New Brunswick, NJ, USA. ykang@princeton.edu.; Ludwig Institute for Cancer Research Princeton Branch, Princeton, NJ, USA. ykang@princeton.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2022 Jan; Vol. 3 (1), pp. 60-74. <i>Date of Electronic Publication: </i>2021 Nov 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35121988 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s43018-021-00280-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 60 Titles: – TitleFull: Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shen M – PersonEntity: Name: NameFull: Smith HA – PersonEntity: Name: NameFull: Wei Y – PersonEntity: Name: NameFull: Jiang YZ – PersonEntity: Name: NameFull: Zhao S – PersonEntity: Name: NameFull: Wang N – PersonEntity: Name: NameFull: Rowicki M – PersonEntity: Name: NameFull: Tang Y – PersonEntity: Name: NameFull: Hang X – PersonEntity: Name: NameFull: Wu S – PersonEntity: Name: NameFull: Wan L – PersonEntity: Name: NameFull: Shao ZM – PersonEntity: Name: NameFull: Kang Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2022 Jan Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2662-1347 Numbering: – Type: volume Value: 3 – Type: issue Value: 1 Titles: – TitleFull: Nature cancer Type: main |
| ResultId | 1 |